Healthcare

NIH Awards Grant to FreshAir

Lebanon, NH – FreshAir, a developer of sensors to detect and alert for hazardous chemicals, has been awarded a Fast-Track Phase II grant totaling over $1.2 million from the National Institute on Drug Abuse, part of the National Institutes of Health (NIH). The 18-month grant will support development of effective vaping sensors for use in schools and other environments.

“We are accelerating the development of our sensors specific to the molecules released during e-cigarette vaping,” said Joseph BelBruno, chief technology officer of FreshAir.

The company offers technology to monitor for, immediately detect, and scientifically prove tobacco smoking and marijuana smoking.

 

 

 

 

Take advantage of High-Profile’s current subscription rates now, by signing up for a monthly or annual subscription!

Learn More!